CompanyStageLast valuationTotal raised
PPluristyx Inc.Pluristyx sells iPSC cell lines and contract development services for cell and gene therapy through its panCELLa platform.Series AHealthcareLast valuationUndisclosedTotal raised$9.8MPPolyrizon Ltd.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$3.5MPPoolbeg Pharma PLCUK public limited company incorporated 2021.PublicHealthcareLast valuationUndisclosedTotal raised$0PPoolbeg Pharma (UK) LimitedUK private limited company incorporated 2021.Late stageHealthcareLast valuationUndisclosedTotal raised$0PPortal Biotechnologies, Inc.Portal Biotechnologies, Inc., founded in 2023 in Arlington, Massachusetts, develops platforms for delivering cargo into cells such as T cells and iPSCs.Series AHealthcareLast valuationUndisclosedTotal raisedSign inPPotrero Medical, Inc.Won a federal SBIR/STTR research award from HHS and other federal agencies.Series AHealthcareLast valuationUndisclosedTotal raisedSign inPPrecision For Medicine (UK), LTDUK private limited company incorporated 2017.Late stageHealthcareLast valuationUndisclosedTotal raised$0PProEncia Biotechnology Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$1.5MPPromptus LLCPrivate securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$100KPPuretech Health PLCUK public limited company incorporated 2015.PublicHealthcareLast valuationUndisclosedTotal raised$0QQlaris Bio, Inc.Qlaris Bio, Inc., co-founded in 2019 in Massachusetts, is a clinical-stage biotech developing the topical therapy QLS-111 for glaucoma.SeedHealthcareLast valuationUndisclosedTotal raisedSign inQQ Squared Solutions China LimitedUK private limited company incorporated 2015.Late stageHealthcareLast valuationUndisclosedTotal raised$0QQ Squared Solutions China (Quest) LimitedUK private limited company incorporated 2015.Late stageHealthcareLast valuationUndisclosedTotal raised$0QQuanta Therapeutics, Inc.Quanta Therapeutics develops allosteric KRAS inhibitors for RAS-driven cancers, with lead candidates in Phase 1 trials.Series CHealthcareLast valuationUndisclosedTotal raisedSign inQQuell Therapeutics LimitedUK private limited company incorporated 2019.Late stageHealthcareLast valuationUndisclosedTotal raisedSign inQQuince Therapeutics, Inc.Quince Therapeutics, Inc., founded in 2012 in South San Francisco, is a biotechnology company that raised USD 485 million in 2023.Series AHealthcareLast valuationUndisclosedTotal raisedSign inRRapalogix Health, Inc.Rapalogix Health develops mTOR-based dermatology therapeutics and professional skincare for skin aging and disease.Series AHealthcareLast valuationUndisclosedTotal raised$19.1MRRecordati UK LTDUK private limited company incorporated 2014.Late stageConsumer & retailLast valuationUndisclosedTotal raised$0RRedx Immunology LimitedUK private limited company incorporated 2014.Late stageHealthcareLast valuationUndisclosedTotal raised$0RReelReactor, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$500KRREGENTIS BIOMATERIALS LTD.Regentis Biomaterials develops GelrinC, a resorbable hydrogel implant for orthopedic tissue repair and regeneration.Series AHealthcareLast valuationUndisclosedTotal raisedSign inR
Rejuvenate Bio IncRaised capital from retail investors through a Regulation Crowdfunding offering on Wefunder Portal LLC.Series AHealthcareLast valuationUndisclosedTotal raisedSign inR
Remedium Bio Inc.Won a federal SBIR/STTR research award from NSF and other federal agencies.SeedHealthcareLast valuationUndisclosedTotal raisedSign inRRenovare Therapeutics, Inc.Private securities offering disclosed via SEC Form D.SeedHealthcareLast valuationUndisclosedTotal raised$100KRReplimune LimitedUK private limited company incorporated 2015.Late stageHealthcareLast valuationUndisclosedTotal raised$0